Skip to content
Study details
Enrolling now

Individualizing Treatment for Asthma in Primary Care (Full Study)

DARTNet Institute
NCT IDNCT07052942ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

3,200

Study length

about 4.3 years

Ages

13–75

Locations

13 sites in CO, FL, KS +7

What this study is about

Researchers are testing whether using inhaled corticosteroids (ICS) or azithromycin as a treatment to reduce asthma attacks in primary care patients. The trial will compare these two approaches individually and together.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Azithromycin
  • 2.Take Inhaled corticosteroid (ICS)
  • 3.Use Asthma Symptom Monitoring Web-based Application

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Injection / IVInjection / IV

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

azithromycin, corticosteroid

Drug routes

injection, intravenous, inhaled

Endpoints

Secondary: Asthma Quality of Life Questionnaire (AQLQ) as Measured by the Juniper Mini Asthma Quality of Life Questionnaire

Body systems

Respiratory